Kintz Samuel

Enliven Therapeutics, Inc. · PRESIDENT AND CEO

Kintz Samuel is listed in public filings as director, officer: PRESIDENT AND CEO. This Kintz Samuel insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN). Investors use Kintz Samuel's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Enliven Therapeutics, Inc.ELVN$273k12.5k sharesSellNov 17, 2025$21.82--